Ahad Eshraghian

Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study

Thomas Marjot, Andrew M. Moon, Jonathan Cook et al. · Journal of Hepatology · 2020 · 519 citations · Full text

Nonalcoholic fatty liver disease in a cluster of Iranian population: thyroid status and metabolic risk factors.

Ahad Eshraghian, Mohammad Hossein Dabbaghmanesh, Hamed Eshraghian et al. · PubMed · 2013 · 101 citations

Helicobacter pylori Infection as a Risk Factor for Insulin Resistance

Ahad Eshraghian, Seyed Ali Hashemi, Alireza Hamidian Jahromi et al. · Digestive Diseases and Sciences · 2008 · 74 citations

Metabolic Syndrome, Diabetes Management, Helicobacter Pylori Infection +8

Vitamin D supplementation for the treatment of non-alcoholic fatty liver disease: A randomized double blind placebo controlled trial

Mohammad Hossein Dabbaghmanesh, Farideh Danafar, Ahad Eshraghian et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 2018 · 50 citations

Obesity, Nutrition, Metabolic Syndrome +10

European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline

Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto et al. · Clinical Nutrition · 2022 · 49 citations · Full text